Medication reference
Rifampin
Monograph awaiting updateThis monograph will be updated in the future.
Historical source. Current clinical review is incomplete. This monograph will be updated in the future.
Rifampin (opens in a new tab)Original source URL: https://globalrph.com/dilution/rifampin/ | Retrieved 2026-11-04
Source dates, location and integrity
This historical article is separate from the reviewed claim cards. Product formulations and source dates may differ.
- Original source URL
- https://globalrph.com/dilution/rifampin/ (opens in a new tab)
- Source date
- Not established in the retrieved source
- Retrieved
- 2026-11-04T19:50:40.597907+00:00
- Source location
- div.post-content
- Packaged content SHA-256
- 1d8487ae6674731c310050e2063cc2a4307b83abb51efc3ece8f7f9a674ff7b1
- Original response SHA-256
- 17c5ba835d7eabec025c78f79debaac8db9dc2ac0752e4f54cb453081a4f9038
- Source body SHA-256
- 086d78732ac0179e9fb12ca6b6f2e2b35ba4a81f6e9652304420ae5e9d6c4ce8
Rifampin |
| The authors make no claims of the accuracy of the information contained herein; and these suggested doses and/or guidelines are not a substitute for clinical judgment. Neither GlobalRPh Inc. nor any other party involved in the preparation of this document shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user's use of or reliance upon this material. PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER. |
Usual Diluents |
| D5W, NS |
Standard Dilutions [Amount of drug] [Infusion volume] [Infusion rate] |
|
Preparation of Solution for IV Infusion: [Admixture stability] Dilutions in dextrose 5% for injection (D5W) are stable at room temperature for up to 8 hours and should be prepared and used within this time. Precipitation of rifampin from the infusion solution may occur beyond this time. Dilutions in normal saline are stable at room temperature for up to 6 hours and should be prepared and used within this time. Other infusion solutions are not recommended. [July 2018] Standard Dilutions [Amount of drug] [Infusion volume] [Infusion rate] Minimum dilution: |
Stability / Miscellaneous |
|
DOSAGE AND ADMINISTRATION ======================================= Rifampin can be administered by the oral route or by IV infusion. IV doses are the same as those for oral. Tuberculosis Meningococcal Carriers STABILITY: PREPARATION of Solution for IV Infusion : Source: [package insert] |
Product identifiers and clinical review status
This monograph will be updated in the future. Historical material is available where present in the original sources; full current exact-product and claim-level review remains pending.
Exact formulation, concentration, container, manufacturer, regulatory identifiers, and a reproducible label snapshot have not all been reconciled.
What remains to be completed
- A retrieved source document is available; clinical reconciliation and a second-source claim map remain incomplete
- Clinically reviewed, individually identified statements with two exact source mappings
- Exact formulation, strength, container, manufacturer/labeler, application and NDC reconciliation
- Renal-function methods and dialysis/CRRT modality review where applicable
- Mechanism provenance, clinical source disagreements and full medication-specific safety reconciliation
Supplemental historical fields
Restored-data provenance and review notes
Source release: 2026-08-31. Current clinical review is incomplete. Original uses of current, verified, or normalized describe the historical source. They do not inherit the status of separately reviewed statements. Product formulations and source dates can differ.
Current review annotations for historical renal, dialysis, mechanism, and product fields
Separate renal reference: Open Renal Dosing Master (opens in a new tab)- Renal
- Status
- not_locally_normalized
- Original classification
- current_label_review_required
- Entries
- General note
- Preserve the source-specific renal-function basis. An indexed CrCl table is not interchangeable with unindexed CrCl or eGFR. Generic advice to check a method does not identify the equation for a dose row.
- Dialysis
- Status
- no_local_structured_regimen
- Entries
- General note
- Named modality alone does not establish applicability. CRRT subtype, effluent rate, residual renal function, timing and interruptions require review. Historical absence is not evidence that no guidance exists.
- Mechanisms
- Source kind
- first_look
- Local pointer
- /mechanism
- Original level
- drug_specific
- Provenance classification
- historical_drug_specific_uncorroborated
- Label derived verified
- false
- Independently corroborated
- false
- Exact label section
- Not recorded
- Original source note
- Not recorded
- Review status
- historical_unverified
- Note
- Drug-specific wording in the old file is not proof of independent corroboration or an exact label locator. Consult separately published current mechanism claims where present.
- Source kind
- label_snapshot
- Local pointer
- /mechanism_summary
- Original level
- drug_specific
- Provenance classification
- historical_drug_specific_uncorroborated
- Label derived verified
- false
- Independently corroborated
- false
- Exact label section
- Not recorded
- Original source note
- GlobalRPh drug-specific mechanism summary retained alongside the selected DailyMed label.
- Review status
- historical_unverified
- Note
- Drug-specific wording in the old file is not proof of independent corroboration or an exact label locator. Consult separately published current mechanism claims where present.
- Future update
- Status
- pending_review
- Message
- This monograph will be updated in the future as current exact-product and claim-level review is completed.
- Source unavailable
- false
- Reason
- The historical content is restored; comprehensive contemporary verification remains incomplete.
Historical first look: uses, mechanism, dosing context, and administration
Recovered v5.1 source content; historical, awaiting current review.
- Id
- rifampin
Source ID
H51-F469B93B9E0C4DBA8545D135 - Generic name
- Rifampin
Source ID
H51-E2CABEDABDBF92E910AF3EF9 - Class
- Antibacterial
Source ID
H51-3EB3C6247B1F5A2F11D3DE02 - Subclass
- Legacy GlobalRPh directory entry
Source ID
H51-E51ED40AC269B1E91AA4477F - Primary uses
- Selected susceptible bacterial infections; indication, site, organism, local susceptibility, and current labeling determine use.
Source ID
H51-34821E4644A30C0895AABC2C
- Selected susceptible bacterial infections; indication, site, organism, local susceptibility, and current labeling determine use.
- Mechanism
- Binds bacterial DNA-dependent RNA polymerase and suppresses RNA transcription.
Source ID
H51-0116259AFACDDCEF0EC87B37 - Mechanism level
- drug_specific
Source ID
H51-9EDE98EBF4EF874F29BD9FF0 - Basic dosing orientation
- Adult IV dosing is indication specific and usually part of combination therapy. Pediatric dosing is weight and indication specific. Neonatal use requires age-specific infectious-disease guidance.
Source ID
H51-D127E13C7BC11D61CD98965B - Administration orientation
- Complete a 100 mL preparation in 30 minutes or a 500 mL preparation within 3 hours. Use a dedicated or compatibility-verified line; rifampin can discolor solutions and body fluids.
Source ID
H51-84CD3F33D3F143D7D0120A11 - Renal and population orientation
- Separate renal reference: Open Renal Dosing Master (opens in a new tab)Renal dosing status has not been locally normalized; use the current package insert before ordering or administration.
Source ID
H51-58687F17516DDA7E89BC5479 - Key safety orientation
- Rifampin is a potent enzyme inducer with extensive interactions. Monitor hepatic function and verify combination therapy.
Source ID
H51-2E6673BF668CB0191821C377 - Legacy content must be reconciled against current labeling and institutional policy before clinical use.
Source ID
H51-0519C9C2AAF8EE1EDF15B9D3
- Rifampin is a potent enzyme inducer with extensive interactions. Monitor hepatic function and verify combination therapy.
- Coverage path
- reviewed_local_label_summary
Source ID
H51-2E6671F4E131DE6017A0520E - Coverage path label
- Reviewed local package-insert summary
Source ID
H51-78877942C34701761E687B5A - Official label url
- https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=036ab68e-5085-4edc-bd83-784b43d64eab (opens in a new tab)
Source ID
H51-BEFC49E082B78C7138160551 - Legacy title
- Rifampin
Source ID
H51-3A2D6E700A8FC01B4E955F16 - Review note
- First-look orientation only. Verify indication, patient population, weight basis, organ function, exact IV product, dose, concentration, compatibility, rate, and current labeling before use.
Source ID
H51-375689024B2425BC77F47841 - Search text
- Rifampin Antibacterial Legacy GlobalRPh directory entry Selected susceptible bacterial infections; indication, site, organism, local susceptibility, and current labeling determine use. Binds bacterial DNA-dependent RNA polymerase and suppresses RNA transcription. Adult IV dosing is indication specific and usually part of combination therapy. Pediatric dosing is weight and indication specific. Neonatal use requires age-specific infectious-disease guidance. Complete a 100 mL preparation in 30 minutes or a 500 mL preparation within 3 hours. Use a dedicated or compatibility-verified line; rifampin can discolor solutions and body fluids. Renal dosing status has not been locally normalized; use the current package insert before ordering or administration. Rifampin is a potent enzyme inducer with extensive interactions. Monitor hepatic function and verify combination therapy. Legacy content must be reconciled against current labeling and institutional policy before clinical use. Reviewed local package-insert summary
Source ID
H51-E03314AE538DEFC404BEE9EC - Official access mode
- direct_label
Source ID
H51-238F202C206F1B685A4B8B53 - Official access url
- https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=036ab68e-5085-4edc-bd83-784b43d64eab (opens in a new tab)
Source ID
H51-A2F3D18F8CC0B335F6907A8A - Official access reason
- A source-specific DailyMed label route is available.
Source ID
H51-7CA1931AF50763149CA6BF51 - Label snapshot available
- true
Source ID
H51-C175874966E1C43831E1D4A9 - Label snapshot setid
- 036ab68e-5085-4edc-bd83-784b43d64eab
Source ID
H51-6F0F2030D12155E42145475B
No separate structured rows were bundled for preparation, IV push, continuous infusion, population dosing, dialysis, CRRT. Historical article content and source links may cover these topics.
Historical local label preparation summary
Recovered v5.1 source content; historical, awaiting current review.
- Id
- rifampin
Source ID
H51-1B5FC290DE3B48D179534113 - Match names
- Rifampin
Source ID
H51-2525418BA157977720199B7D - Rifadin IV
Source ID
H51-A6696C24E0E6BE492B3202DF
- Rifampin
- Label title
- Rifampin for injection
Source ID
H51-E6C34ECEE5DAEE10FFD93332 - Brand names
- Rifadin IV
Source ID
H51-7D6E36CB74E46C20E4F10612
- Rifadin IV
- Formulation
- RIFADIN IV is supplied as a 600 mg lyophilized single-dose vial.
Source ID
H51-4DA8C7A6FB44BBF4B20A4B99 - Reconstitution
- Reconstitute a 600 mg vial with 10 mL Sterile Water for Injection to produce approximately 60 mg/mL.
Source ID
H51-B3872F84BD036666AB600FFE - Stock concentration
- Approximately 60 mg/mL after reconstitution.
Source ID
H51-65A6F53CEE16502136BC3182 - Diluents
- Further dilute in 5% dextrose injection or 0.9% sodium chloride injection as allowed by the exact label.
Source ID
H51-7B2D040A1FB2AE2295CEF2ED - Final concentration
- Withdraw the calculated dose from the 60 mg/mL reconstituted vial and add it to either 100 mL or 500 mL of infusion medium, as directed by the current label.
Source ID
H51-9686E85F5C01EBDF899F0C74 - Containers
- Use 100 mL for a 30-minute infusion or 500 mL for an infusion completed within 3 hours.
Source ID
H51-632B8CDDDE1B3A2ED495083E - Infusion time
- Complete a 100 mL preparation in 30 minutes or a 500 mL preparation within 3 hours.
Source ID
H51-21D95DF2E638A12A913DD74D - Fluid restriction
- Use the reduced-volume option only within the exact label concentration and administration limits.
Source ID
H51-36F4D1583832B65AC63BEB99 - Stability
- The reconstituted 60 mg/mL vial solution is stable at room temperature for up to 30 hours. D5W dilutions should be used within 8 hours; normal-saline dilutions within 6 hours.
Source ID
H51-6668259E53698B22A66962CC - Line filter
- Use a dedicated or compatibility-verified line; rifampin can discolor solutions and body fluids.
Source ID
H51-F025D976AD88130CE8BBCD33 - Adult applicability
- Adult IV dosing is indication specific and usually part of combination therapy.
Source ID
H51-BDC9517113E78FBFF9E4F0C1 - Pediatric applicability
- Pediatric dosing is weight and indication specific.
Source ID
H51-93463EA17B93DC393FCFB5C2 - Neonatal applicability
- Neonatal use requires age-specific infectious-disease guidance.
Source ID
H51-A9F071B93B32D101E75CA6A7 - Renal dialysis
- Separate renal reference: Open Renal Dosing Master (opens in a new tab)Renal adjustment is not usually the primary determinant, but hepatic function and interacting medicines require review.
Source ID
H51-06F0B4569AA378E17E691305 - Key warnings
- Rifampin is a potent enzyme inducer with extensive interactions. Monitor hepatic function and verify combination therapy.
Source ID
H51-4A92915A2BEBEA18DF02B075 - Catalog id
- rifampin
Source ID
H51-429C40C7945FF246A9EF854E - Catalog name
- Rifampin
Source ID
H51-68F2748B0E41A48752D93E7E - Review date
- 2026-08-30
Source ID
H51-DC63F968E8B294B61A89B7CD - Source type
- Reviewed local summary derived from official DailyMed labeling; exact marketed product must be checked.
Source ID
H51-5A626E8EECF536371DC3CFC1 - Official link type
- DailyMed official label
Source ID
H51-E242B47E6038F81F56658CF8 - Official label url
- https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=036ab68e-5085-4edc-bd83-784b43d64eab (opens in a new tab)
Source ID
H51-1EB7D30FEC209D803945D878 - Official search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Rifampin+for+injection (opens in a new tab)
Source ID
H51-AB9EA6F9950F7BAEF8FC640A - Search text
- Rifampin Rifadin IV Rifadin IV rifampin rifampin Rifampin Rifampin for injection RIFADIN IV is supplied as a 600 mg lyophilized single-dose vial. Reconstitute a 600 mg vial with 10 mL Sterile Water for Injection to produce approximately 60 mg/mL. Approximately 60 mg/mL after reconstitution. Further dilute in 5% dextrose injection or 0.9% sodium chloride injection as allowed by the exact label. Withdraw the calculated dose from the 60 mg/mL reconstituted vial and add it to either 100 mL or 500 mL of infusion medium, as directed by the current label. Use 100 mL for a 30-minute infusion or 500 mL for an infusion completed within 3 hours. Complete a 100 mL preparation in 30 minutes or a 500 mL preparation within 3 hours. Use the reduced-volume option only within the exact label concentration and administration limits. The reconstituted 60 mg/mL vial solution is stable at room temperature for up to 30 hours. D5W dilutions should be used within 8 hours; normal-saline dilutions within 6 hours. Use a dedicated or compatibility-verified line; rifampin can discolor solutions and body fluids. Adult IV dosing is indication specific and usually part of combination therapy. Pediatric dosing is weight and indication specific. Neonatal use requires age-specific infectious-disease guidance. Renal adjustment is not usually the primary determinant, but hepatic function and interacting medicines require review. Rifampin is a potent enzyme inducer with extensive interactions. Monitor hepatic function and verify combination therapy. Current DailyMed label page located during the 2026-08-30 review; confirm the exact NDC and marketed product at the point of use. Reviewed local summary derived from official DailyMed labeling; exact marketed product must be checked. DailyMed official label 2026-08-30
Source ID
H51-B3496447FCB48F263E422C6E - Label status
- Current DailyMed label page located during the 2026-08-30 review; confirm the exact NDC and marketed product at the point of use.
Source ID
H51-8E77E52A83AD483F4BAE0D56 - Label status level
- current
Source ID
H51-C76F305AD8D3128944C7EBA6
Historical DailyMed label snapshot
Recovered v5.1 source content; historical, awaiting current review.
- Id
- rifampin
Source ID
H51-481FC6ECFE9E968543985952 - Catalog name
- Rifampin
Source ID
H51-6BF265B2384D879CA43ECDB0 - Selection status
- accepted_high_confidence
Source ID
H51-D19738C359DA089446B555F8 - Confidence
- very_high
Source ID
H51-693C9894F68ACAF66617CAA8 - Match path
- existing_reviewed_summary
Source ID
H51-586DF05B1E066F2FCA82760A - Brand name
- Rifadin IV
Source ID
H51-836B583B8C1C8DACA23BEA06 - Label title
- Rifampin for injection
Source ID
H51-6FC15F204ACF8ED6CD902702 - Setid
- 036ab68e-5085-4edc-bd83-784b43d64eab
Source ID
H51-6037DD9DB5D94732CA96072A - Official label url
- https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=036ab68e-5085-4edc-bd83-784b43d64eab (opens in a new tab)
Source ID
H51-27555A34E9CA293B402D1771 - Reviewed on
- 2026-08-31
Source ID
H51-93F89891E33201B7BEA2BE59 - Route
- Intravenous; see the selected product label for exact route and administration method.
Source ID
H51-82BE58B1E360B021A01BB2EB - Dosage form
- RIFADIN IV is supplied as a 600 mg lyophilized single-dose vial.
Source ID
H51-219B18F638ED55AF97F592DF - Dosage administration summary
- Separate renal reference: Open Renal Dosing Master (opens in a new tab)
- Adult IV dosing is indication specific and usually part of combination therapy.
Source ID
H51-E7A888349A964E0D18A93304 - Pediatric dosing is weight and indication specific.
Source ID
H51-D8DE0B6A76ED7CD60129A8D5 - Neonatal use requires age-specific infectious-disease guidance.
Source ID
H51-E055A728E233466409723940 - Reconstitute a 600 mg vial with 10 mL Sterile Water for Injection to produce approximately 60 mg/mL.
Source ID
H51-A8C28BC81CDAE1AAACC37195 - Complete a 100 mL preparation in 30 minutes or a 500 mL preparation within 3 hours.
Source ID
H51-C05379FB802593AF06C59E68 - Renal adjustment is not usually the primary determinant, but hepatic function and interacting medicines require review.
Source ID
H51-FAB57FA50B0F82B82C5E0F0A
- Adult IV dosing is indication specific and usually part of combination therapy.
- Dosage forms strengths
- RIFADIN IV is supplied as a 600 mg lyophilized single-dose vial.
Source ID
H51-4EAEDBE4276CEEC1DFD4D4BB - Approximately 60 mg/mL after reconstitution.
Source ID
H51-2C5251B2F14FA1330C9BBD5A
- RIFADIN IV is supplied as a 600 mg lyophilized single-dose vial.
- Mechanism summary
- Binds bacterial DNA-dependent RNA polymerase and suppresses RNA transcription.
Source ID
H51-13429CFD17199BF5A678224A - Mechanism source
- GlobalRPh drug-specific mechanism summary retained alongside the selected DailyMed label.
Source ID
H51-E95E5263FE2901D9CE6A50ED - Scope note
- The locally reviewed preparation summary remains the primary product-specific preparation snapshot. This broader label snapshot is concise and does not reproduce the full prescribing information.
Source ID
H51-CAE99A4F7CAFAE01853F5A43 - Source sections
- Dosage and Administration
Source ID
H51-5BD0529611EA2A54A6B52EB6 - Dosage Forms and Strengths
Source ID
H51-8001728798EC03C6B36056AD - Clinical Pharmacology or Microbiology as applicable
Source ID
H51-5FD984008E17D6EFD5366223
- Dosage and Administration
- Retrieval method
- Manual build-time review of the current DailyMed full prescribing information for the selected Set ID; no live server retrieval is required during page use.
Source ID
H51-8C901BFF191EF7374C9CAA8A - Label status
- current
Source ID
H51-B8AFA4EA3FEE1EF894629A88 - Disclaimer
- Verify the exact formulation, strength, manufacturer, NDC, route, current label revision, patient-specific order, institutional policy, and monitoring before use.
Source ID
H51-80ADBF6BCDC04DB606406D1C
Historical renal-function guidance
Recovered v5.1 source content; historical, awaiting current review.
Separate renal reference: Open Renal Dosing Master (opens in a new tab)- Classification
- current_label_review_required
Source ID
H51-09D400D63F6F7925922F7DA3 - Summary
- Renal dosing status has not been locally normalized; use the current package insert before ordering or administration.
Source ID
H51-1DCCF934FA15750F9CBD8848 - Method note
- Use the renal function estimate and body-size convention specified by the selected label or institutional protocol. Do not interchange Cockcroft-Gault CrCl, indexed eGFR, and de-indexed eGFR without confirming the dosing source.
Source ID
H51-5ED048D0CB66F8BEE60613B7
Historical Warnings and safeguards
Recovered v5.1 source content; historical, awaiting current review.
- Legacy content must be reconciled against current labeling and institutional policy before clinical use.
Source ID
H51-F35E7E26E5C48796CA8DD37D
Historical Stability notes
Recovered v5.1 source content; historical, awaiting current review.
- Legacy product stability information is not automatically equivalent to a USP <797> BUD.
Source ID
H51-4E2A9A665C9CAEBA38E04380
Historical supplemental professional sources
Recovered v5.1 source content; historical, awaiting current review.
| Label | Url | Kind |
|---|---|---|
Source IDH51-38262BCEB7DE449D6A66480DSource IDH51-84B7E1B42EEBF083CE007DFD | https://idmp.ucsf.edu/adult-antimicrobial-dosing-non-dialysis (opens in a new tab)Source IDH51-7A87528CD233DD04CFEFF192 | Professional institutional guidanceSource IDH51-0062B50762FAFB9BF2A7398E |
Source IDH51-04A6AF5C1612F7D4DE475F93Source IDH51-E674D6C54E93A1008768C82D | https://idmp.ucsf.edu/antimicrobial-dosing-intermittent-continuous-hemodialysis (opens in a new tab)Source IDH51-868182C20E34B7ABF8D761C5 | Professional institutional guidanceSource IDH51-03FA1DF30338BC6625F51E4F |
Source IDH51-CCFB5184DB043ED7AB3A48D9Source IDH51-E6B1D07070992A993B16AA5D | https://idmp.ucsf.edu/pediatric-antimicrobial-dosing-benioff-childrens-hospitals (opens in a new tab)Source IDH51-C76C289D21F88F0A0BC4DDBB | Professional institutional guidanceSource IDH51-C8ED5DBBE78950DC6C46E174 |
Source IDH51-9BA13BED9A99BDBE520E6CE1Source IDH51-9476D300450DB3B644BBF3F4 | https://idmp.ucsf.edu/neonatal-antimicrobial-dosing-benioff-childrens-hospitals (opens in a new tab)Source IDH51-3AE104229F75494E4D8687EF | Professional institutional guidanceSource IDH51-E3ACEE7951F805D9E0F76227 |
Other recovered source fields and original editorial metadata
Original status words such as current, verified, or normalized describe the historical source release. They do not change the clinical review status of this release.
Catalog source fields
Id
rifampinSource ID
H51-0DCA64CB0BF1607FCCE9D472Legacy title
RifampinSource ID
H51-3402EA904A721C9DE1B195A9Generic name
RifampinSource ID
H51-0C34966F78CA4502830C4E65Class
AntibacterialSource ID
H51-BA0EE8CED27105FB446CBDF0Subclass
Legacy GlobalRPh directory entrySource ID
H51-A1E8FBE39C4C1A2A63A68B35Summary
Existing GlobalRPh IV dilution monograph retained for migration into the unified reference.Source ID
H51-BA9C5E7F6624A061763CAB92Populations
- Population not yet normalized
Source ID
H51-F1F964E0B4B5F4EA100A42AF
Evidence tier
Reviewed local label summary - exact product confirmation requiredSource ID
H51-9164545B86FD6F653BDE36F0High alert
falseSource ID
H51-28CDAE1B6A1FC3F4230CAC4CHazardous
falseSource ID
H51-92FBB2CB9A6B3A128C992EBDStatus
Legacy migrationSource ID
H51-9E45334D126430929ABE5FBBReviewed
2026-08-30Source ID
H51-5A6672E2A2166C0E34417DADVersion added
LegacySource ID
H51-AC6F0346D46304FB0B262001Sources
| Label | Url | Kind |
|---|---|---|
Source IDH51-06934D849AF439E4D5399CF3Source IDH51-936E76BCD755F61F7D6FAB04 | legacy:autoSource IDH51-CBEBEEB515D827D0A0C829C7 | LegacySource IDH51-2AF97D540F73680026A3626E |
Clinical release verification
- Audit version
- 3.4
Source ID
H51-B8FD8766A507BB86A4C15747 - Audited on
- 2026-08-30
Source ID
H51-3474070E2E945C750EE7D3CD - Level
- amber
Source ID
H51-99F3E7551ED5C4FB961518EB - Release gate
- trusted_professional_source_present_exact_label_unconfirmed
Source ID
H51-38E479AA820D4E411A9615A2 - Exact current label candidate
- false
Source ID
H51-FE0029F167FECB9AE9BF6FA5 - Reference url count
- 4
Source ID
H51-732A27DD2CEB8820A4EFEA80 - Broken reference count
- 0
Source ID
H51-FFC4B4CA6BA98AC99F964347 - Point of use confirmation required
- true
Source ID
H51-66844A6315946576FCA7E7B2 - Note
- Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
Source ID
H51-6436D0E887D45330159EB80C - Dailymed search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Rifampin (opens in a new tab)
Source ID
H51-FCFA00ADB76854BCE3F88A6B
Version updated
3.8Source ID
H51-DCBDD4A297EA31AB379FE531Dosing source fields
Id
rifampinSource ID
H51-9791F2E9BD1F0749971623B3Generic name
RifampinSource ID
H51-2B01014BA615572617FA2527Coverage status
direct_official_label_access_plus_legacy_referenceSource ID
H51-CD59DA329667A3E66F124E87Package insert
- Query name
- Rifampin
Source ID
H51-2DCAAB13C6E992196519C525 - Product and route must match
- true
Source ID
H51-7C0EBDF445FD5F47755B8BEB - Live current label enabled
- false
Source ID
H51-7C41885472A63AFCD13748FA - Source priority
- Reviewed local summary when available, then a verified DailyMed label or product search when available, followed by professional references and institutional policy.
Source ID
H51-9D08B453CBC284375B786827 - Direct official label access enabled
- true
Source ID
H51-321420625DBE4D42CADE8DC8 - Outbound server request required
- false
Source ID
H51-254A1061458FAB30E0ABF2BA - Local summary status
- current_reviewed_summary
Source ID
H51-6D7396EE6CFF52F5B8F94693
Clinical review
- Locally normalized
- false
Source ID
H51-DF93AF526C09246B54C95C14 - Reviewed
- 2026-08-29
Source ID
H51-53035B5D572978DB72B181F2 - Status
- Direct official package-insert access enabled; indication-specific local normalization pending.
Source ID
H51-9F99056C641E905F7DA0839F
Clinical release verification
- Audit version
- 3.4
Source ID
H51-645FE3D0959F18C478E70F23 - Audited on
- 2026-08-30
Source ID
H51-A4B933761B5CB12F40A0D019 - Level
- amber
Source ID
H51-5072FDBC083F91AF5B516CFB - Release gate
- trusted_professional_source_present_exact_label_unconfirmed
Source ID
H51-862FBFAD8DF7EEC084DFE570 - Exact current label candidate
- false
Source ID
H51-55D66C733CCA6878F598378B - Reference url count
- 4
Source ID
H51-A5C59FC1D0AA5F5E9316FA6A - Broken reference count
- 0
Source ID
H51-BFB9B77420A6707AAF439A06 - Point of use confirmation required
- true
Source ID
H51-D250F9FDA4CD1380069E04FA - Note
- Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
Source ID
H51-DED50084BD139D154D2B156E - Dailymed search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Rifampin (opens in a new tab)
Source ID
H51-4A26CED636B259C641D58258
Historical preparation assessment
Recovered v5.1 source content; historical, awaiting current review.
- Id
- rifampin
Source ID
H51-02E4FB76A547572A16557864 - Name
- Rifampin
Source ID
H51-F2CF0B10CB2F7D025084B802 - Therapeutic class
- Antibacterial
Source ID
H51-451CEF3CA6B18D8A060C248E - Review version
- 3.8
Source ID
H51-5EAF8E57FB421EDAE427DB9D - Review date
- 2026-08-30
Source ID
H51-4A6AC86AE2DC92B6B8A91A7A - Release status
- reviewed_local_label_summary_exact_product_confirmation_required
Source ID
H51-751B35C37A39BA08DF87FDAD - Market status
- Status
- current_dailymed_label_page_located_exact_product_verification_required
Source ID
H51-CABDA9AF35E31412BEA5DE20 - Basis
- Current DailyMed label page located during the 2026-08-30 review; confirm the exact NDC and marketed product at the point of use.
Source ID
H51-56E104B46604D1C04315ABC8
- Ten point assessment
- Exact formulation
- RIFADIN IV is supplied as a 600 mg lyophilized single-dose vial.
Source ID
H51-3282E84E495246CCC967B498 - Reconstitution concentration
- Reconstitute a 600 mg vial with 10 mL Sterile Water for Injection to produce approximately 60 mg/mL. Approximately 60 mg/mL after reconstitution.
Source ID
H51-6CBF681EA0204CE724E2B797 - Maximum or recommended final concentration
- Withdraw the calculated dose from the 60 mg/mL reconstituted vial and add it to either 100 mL or 500 mL of infusion medium, as directed by the current label.
Source ID
H51-1306D6342FFCBEA8CB7B6B18 - Appropriate standardized containers
- Use 100 mL for a 30-minute infusion or 500 mL for an infusion completed within 3 hours.
Source ID
H51-B4174DCC184E8B41A8B5B1EE - Adult dosing range
- Adult IV dosing is indication specific and usually part of combination therapy.
Source ID
H51-82F6E13E8A24DF2A192425A1 - Pediatric dosing range
- Pediatric dosing is weight and indication specific.
Source ID
H51-93C4B67753BA672C4EA89698 - Neonatal dosing range
- Neonatal use requires age-specific infectious-disease guidance.
Source ID
H51-AADE8795749C81B3C1E5E707 - Infusion time
- Complete a 100 mL preparation in 30 minutes or a 500 mL preparation within 3 hours.
Source ID
H51-3C091E1ADC4A8C7F8619D99F - Fluid restriction alternatives
- Use the reduced-volume option only within the exact label concentration and administration limits.
Source ID
H51-FCF97FA0945CCE2C4C6451E1 - Current manufacturer labeling
- Setid
- 036ab68e-5085-4edc-bd83-784b43d64eab
Source ID
H51-3149B23F1CBCF037099E543A - Title
- Rifampin for injection
Source ID
H51-CBD52DFCB58C92206CF59DDC - Routes
- INTRAVENOUS
Source ID
H51-C491904B75102E74EF9CA4F2
- INTRAVENOUS
- Match confidence
- reviewed_local_label_summary
Source ID
H51-DFBB67B21BBF6AFA2300A9AA - Url
- https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=036ab68e-5085-4edc-bd83-784b43d64eab (opens in a new tab)
Source ID
H51-C77DB6555F8B7F221BDF82A9
- Field provenance
- Exact formulation
- Primary
- official_dailymed_local_label_summary
Source ID
H51-736327DEA5C3F79E379F4DDB
- Reconstitution concentration
- Primary
- official_dailymed_local_label_summary
Source ID
H51-A1CC00A12AC0B93527B7A83A
- Maximum or recommended final concentration
- Primary
- official_dailymed_local_label_summary
Source ID
H51-F3194E66E1E8AC2F0250016E
- Appropriate standardized containers
- Primary
- official_dailymed_local_label_summary
Source ID
H51-35F1D64E72D6408B0360F8F7
- Adult dosing range
- Primary
- official_dailymed_local_label_summary
Source ID
H51-120FE3E8049E8356380D9B90
- Pediatric dosing range
- Primary
- official_dailymed_local_label_summary
Source ID
H51-999FEC991323DEAC9B4EE3FF
- Neonatal dosing range
- Primary
- official_dailymed_local_label_summary
Source ID
H51-CBC11A68A10A59AA28F988B6
- Infusion time
- Primary
- official_dailymed_local_label_summary
Source ID
H51-0BC186B8C0745AC5095F4401
- Fluid restriction alternatives
- Primary
- official_dailymed_local_label_summary
Source ID
H51-53BDCAE722DAB5D035208069
- Current manufacturer labeling
- Primary
- official_dailymed_local_label_summary
Source ID
H51-53E742354DE4500719DA33F6
- Population applicability
- Adult
- Applicability
- supported_or_source_present
Source ID
H51-097B5E4572E0E2B02EDBB723 - Guide generation allowed
- false
Source ID
H51-635213027D55FB9DFD66357A
- Pediatric
- Applicability
- supported_or_source_present
Source ID
H51-51637D4EF70A59B94300237D - Guide generation allowed
- false
Source ID
H51-1216F3674A391161018BCDC8
- Neonatal
- Applicability
- not_established_or_requires_separate_guidance
Source ID
H51-17990709FEDA8FBB92C0A05F - Guide generation allowed
- false
Source ID
H51-8CAE0EF9EC317DD4490D0C4B
- Route presence
- Structured dilution
- false
Source ID
H51-1AE4929DF2399A1CD0AF58F5 - Iv push
- false
Source ID
H51-FEA83BE437B6D9EB6C92DD25 - Continuous infusion
- false
Source ID
H51-C75E54FA76455E5A043DAEF9 - Pediatric source
- true
Source ID
H51-2812A57AC20C22F24F430997 - Neonatal source
- true
Source ID
H51-DB04A13FF2EB7B2714E40171
- Legacy reference
- Status
- not_available
Source ID
H51-3ADE5C6B1EDB7D5A29EC709B
- Label resolution
- Status
- reviewed_current_official_label_page
Source ID
H51-B6123090FAC764CDCB1F46BB - Existing setids
- 036ab68e-5085-4edc-bd83-784b43d64eab
Source ID
H51-019489DF59C75E7C1DBFA490
- 036ab68e-5085-4edc-bd83-784b43d64eab
- Official url
- https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=036ab68e-5085-4edc-bd83-784b43d64eab (opens in a new tab)
Source ID
H51-EF7CD852E013650E2E25DD4E - Review date
- 2026-08-30
Source ID
H51-8CE2D8F80033A56EC964A8A3
- Source files
- catalog.json
Source ID
H51-FF60F58F3B66ED34FF64E5C4 - dosing.json
Source ID
H51-282D286B79CF6CA59380594C - legacy-map.json
Source ID
H51-02DC717C0160E27729412DE6 - review-queue.json
Source ID
H51-DDD30658A81881D59D44E39C
- catalog.json
- Clinical release note
- Reviewed local summary is available. Confirm exact formulation, NDC, manufacturer, route, current marketed status, compatibility, and institutional policy before use.
Source ID
H51-47E10B3C105207F622EA4C84 - Has bundled label summary
- true
Source ID
H51-0F717ABBC61A78F05B3DEEBE - Bundled label summary id
- rifampin
Source ID
H51-8610A490168A442629FD781B - Bundled label review date
- 2026-08-30
Source ID
H51-3DA83353304D00CBB787D1FB - Local label search
- rifampin Rifampin Rifadin IV Rifampin for injection Rifadin IV Lyophilized rifampin vial, commonly 600 mg. Reconstitute a 600 mg vial with 10 mL Sterile Water for Injection to produce approximately 60 mg/mL. Approximately 60 mg/mL after reconstitution. Further dilute in 5% dextrose injection or 0.9% sodium chloride injection as allowed by the exact label. Use a label-supported final volume; common preparations place 600 mg in 100 to 500 mL depending on infusion duration and fluid status. Common options include 100 mL for a shorter controlled infusion or 500 mL for a longer infusion, subject to the exact label. Administer by controlled infusion; common labeled options complete a 100 mL preparation in about 30 minutes or a 500 mL preparation within approximately 3 hours. Use the reduced-volume option only within the exact label concentration and administration limits. D5W and normal-saline preparations have different labeled stability windows; prepare and administer within the exact product limit. Use a dedicated or compatibility-verified line; rifampin can discolor solutions and body fluids. Adult IV dosing is indication specific and usually part of combination therapy. Pediatric dosing is weight and indication specific. Neonatal use requires age-specific infectious-disease guidance. Renal adjustment is not usually the primary determinant, but hepatic function and interacting medicines require review. Rifampin is a potent enzyme inducer with extensive interactions. Monitor hepatic function and verify combination therapy. rifampin Rifampin 2026-08-30 Reviewed local summary derived from official DailyMed labeling; exact marketed product must be checked. DailyMed official label
Source ID
H51-39AA6633159B8C9C5A070E52 - Aliases
- Rifampin for injection
Source ID
H51-9847126642531989EC48BEF7 - Approximately 60 mg/mL after reconstitution.
Source ID
H51-2A5C0BBE35E6B8A21E3FFE4D - Further dilute in 5% dextrose injection or 0.9% sodium chloride injection as allowed by the exact label.
Source ID
H51-4F4C6C34012631634E89AB70 - Use a label-supported final volume; common preparations place 600 mg in 100 to 500 mL depending on infusion duration and fluid status.
Source ID
H51-5EB5058C52C6E8EDCA47D750 - Administer by controlled infusion; common labeled options complete a 100 mL preparation in about 30 minutes or a 500 mL preparation within approximately 3 hours.
Source ID
H51-F5E878FE2B07BD6A2625D5E7
- Rifampin for injection
- Local label summary
- Available
- true
Source ID
H51-3826DA96DCB5BEDDE7A56956 - Status level
- current
Source ID
H51-9A4E5C076F3B3BB5714D2F10 - Title
- Rifampin for injection
Source ID
H51-D28E129187706D57F071AEBA - Official url
- https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=036ab68e-5085-4edc-bd83-784b43d64eab (opens in a new tab)
Source ID
H51-072724CC765D79CD53D1CB60
Historical statement IDs and source locations
These IDs identify recovered source units. They are not evidence-qualified clinical claims.
| Historical ID | Original source location | Status |
|---|---|---|
H51-0DCA64CB0BF1607FCCE9D472 | catalog.json/records/221/id | Historical; current review incomplete |
H51-3402EA904A721C9DE1B195A9 | catalog.json/records/221/legacy_title | Historical; current review incomplete |
H51-0C34966F78CA4502830C4E65 | catalog.json/records/221/generic_name | Historical; current review incomplete |
H51-BA0EE8CED27105FB446CBDF0 | catalog.json/records/221/class | Historical; current review incomplete |
H51-A1E8FBE39C4C1A2A63A68B35 | catalog.json/records/221/subclass | Historical; current review incomplete |
H51-BA9C5E7F6624A061763CAB92 | catalog.json/records/221/summary | Historical; current review incomplete |
H51-F35E7E26E5C48796CA8DD37D | catalog.json/records/221/warnings/0 | Historical; current review incomplete |
H51-4E2A9A665C9CAEBA38E04380 | catalog.json/records/221/stability_notes/0 | Historical; current review incomplete |
H51-F1F964E0B4B5F4EA100A42AF | catalog.json/records/221/populations/0 | Historical; current review incomplete |
H51-9164545B86FD6F653BDE36F0 | catalog.json/records/221/evidence_tier | Historical; current review incomplete |
H51-28CDAE1B6A1FC3F4230CAC4C | catalog.json/records/221/high_alert | Historical; current review incomplete |
H51-92FBB2CB9A6B3A128C992EBD | catalog.json/records/221/hazardous | Historical; current review incomplete |
H51-9E45334D126430929ABE5FBB | catalog.json/records/221/status | Historical; current review incomplete |
H51-5A6672E2A2166C0E34417DAD | catalog.json/records/221/reviewed | Historical; current review incomplete |
H51-AC6F0346D46304FB0B262001 | catalog.json/records/221/version_added | Historical; current review incomplete |
H51-06934D849AF439E4D5399CF3 | catalog.json/records/221/sources/0 | Historical; current review incomplete |
H51-936E76BCD755F61F7D6FAB04 | catalog.json/records/221/sources/0/label | Historical; current review incomplete |
H51-CBEBEEB515D827D0A0C829C7 | catalog.json/records/221/sources/0/url | Historical; current review incomplete |
H51-2AF97D540F73680026A3626E | catalog.json/records/221/sources/0/kind | Historical; current review incomplete |
H51-B8FD8766A507BB86A4C15747 | catalog.json/records/221/clinical_release_verification/audit_version | Historical; current review incomplete |
H51-3474070E2E945C750EE7D3CD | catalog.json/records/221/clinical_release_verification/audited_on | Historical; current review incomplete |
H51-99F3E7551ED5C4FB961518EB | catalog.json/records/221/clinical_release_verification/level | Historical; current review incomplete |
H51-38E479AA820D4E411A9615A2 | catalog.json/records/221/clinical_release_verification/release_gate | Historical; current review incomplete |
H51-FE0029F167FECB9AE9BF6FA5 | catalog.json/records/221/clinical_release_verification/exact_current_label_candidate | Historical; current review incomplete |
H51-09C0AFE143D0CE13FAF23CE6 | catalog.json/records/221/clinical_release_verification/selected_setid | Historical; current review incomplete |
H51-E2180243359635038B146DD9 | catalog.json/records/221/clinical_release_verification/selected_label_title | Historical; current review incomplete |
H51-05A7431A2EA2569B6FB821C8 | catalog.json/records/221/clinical_release_verification/numeric_support_ratio | Historical; current review incomplete |
H51-732A27DD2CEB8820A4EFEA80 | catalog.json/records/221/clinical_release_verification/reference_url_count | Historical; current review incomplete |
H51-FFC4B4CA6BA98AC99F964347 | catalog.json/records/221/clinical_release_verification/broken_reference_count | Historical; current review incomplete |
H51-66844A6315946576FCA7E7B2 | catalog.json/records/221/clinical_release_verification/point_of_use_confirmation_required | Historical; current review incomplete |
H51-6436D0E887D45330159EB80C | catalog.json/records/221/clinical_release_verification/note | Historical; current review incomplete |
H51-FCFA00ADB76854BCE3F88A6B | catalog.json/records/221/clinical_release_verification/dailymed_search_url | Historical; current review incomplete |
H51-DCBDD4A297EA31AB379FE531 | catalog.json/records/221/version_updated | Historical; current review incomplete |
H51-481FC6ECFE9E968543985952 | dailymed-label-snapshots-v5.1.json/records/42/id | Historical; current review incomplete |
H51-6BF265B2384D879CA43ECDB0 | dailymed-label-snapshots-v5.1.json/records/42/catalog_name | Historical; current review incomplete |
H51-D19738C359DA089446B555F8 | dailymed-label-snapshots-v5.1.json/records/42/selection_status | Historical; current review incomplete |
H51-693C9894F68ACAF66617CAA8 | dailymed-label-snapshots-v5.1.json/records/42/confidence | Historical; current review incomplete |
H51-586DF05B1E066F2FCA82760A | dailymed-label-snapshots-v5.1.json/records/42/match_path | Historical; current review incomplete |
H51-836B583B8C1C8DACA23BEA06 | dailymed-label-snapshots-v5.1.json/records/42/brand_name | Historical; current review incomplete |
H51-6FC15F204ACF8ED6CD902702 | dailymed-label-snapshots-v5.1.json/records/42/label_title | Historical; current review incomplete |
H51-A2BAB29C1EC29BC4E5424BA0 | dailymed-label-snapshots-v5.1.json/records/42/labeler | Historical; current review incomplete |
H51-6037DD9DB5D94732CA96072A | dailymed-label-snapshots-v5.1.json/records/42/setid | Historical; current review incomplete |
H51-27555A34E9CA293B402D1771 | dailymed-label-snapshots-v5.1.json/records/42/official_label_url | Historical; current review incomplete |
H51-93F89891E33201B7BEA2BE59 | dailymed-label-snapshots-v5.1.json/records/42/reviewed_on | Historical; current review incomplete |
H51-82BE58B1E360B021A01BB2EB | dailymed-label-snapshots-v5.1.json/records/42/route | Historical; current review incomplete |
H51-219B18F638ED55AF97F592DF | dailymed-label-snapshots-v5.1.json/records/42/dosage_form | Historical; current review incomplete |
H51-E7A888349A964E0D18A93304 | dailymed-label-snapshots-v5.1.json/records/42/dosage_administration_summary/0 | Historical; current review incomplete |
H51-D8DE0B6A76ED7CD60129A8D5 | dailymed-label-snapshots-v5.1.json/records/42/dosage_administration_summary/1 | Historical; current review incomplete |
H51-E055A728E233466409723940 | dailymed-label-snapshots-v5.1.json/records/42/dosage_administration_summary/2 | Historical; current review incomplete |
H51-A8C28BC81CDAE1AAACC37195 | dailymed-label-snapshots-v5.1.json/records/42/dosage_administration_summary/3 | Historical; current review incomplete |
H51-C05379FB802593AF06C59E68 | dailymed-label-snapshots-v5.1.json/records/42/dosage_administration_summary/4 | Historical; current review incomplete |
H51-FAB57FA50B0F82B82C5E0F0A | dailymed-label-snapshots-v5.1.json/records/42/dosage_administration_summary/5 | Historical; current review incomplete |
H51-4EAEDBE4276CEEC1DFD4D4BB | dailymed-label-snapshots-v5.1.json/records/42/dosage_forms_strengths/0 | Historical; current review incomplete |
H51-2C5251B2F14FA1330C9BBD5A | dailymed-label-snapshots-v5.1.json/records/42/dosage_forms_strengths/1 | Historical; current review incomplete |
H51-13429CFD17199BF5A678224A | dailymed-label-snapshots-v5.1.json/records/42/mechanism_summary | Historical; current review incomplete |
H51-E95E5263FE2901D9CE6A50ED | dailymed-label-snapshots-v5.1.json/records/42/mechanism_source | Historical; current review incomplete |
H51-CAE99A4F7CAFAE01853F5A43 | dailymed-label-snapshots-v5.1.json/records/42/scope_note | Historical; current review incomplete |
H51-5BD0529611EA2A54A6B52EB6 | dailymed-label-snapshots-v5.1.json/records/42/source_sections/0 | Historical; current review incomplete |
H51-8001728798EC03C6B36056AD | dailymed-label-snapshots-v5.1.json/records/42/source_sections/1 | Historical; current review incomplete |
H51-5FD984008E17D6EFD5366223 | dailymed-label-snapshots-v5.1.json/records/42/source_sections/2 | Historical; current review incomplete |
H51-8C901BFF191EF7374C9CAA8A | dailymed-label-snapshots-v5.1.json/records/42/retrieval_method | Historical; current review incomplete |
H51-B8AFA4EA3FEE1EF894629A88 | dailymed-label-snapshots-v5.1.json/records/42/label_status | Historical; current review incomplete |
H51-80ADBF6BCDC04DB606406D1C | dailymed-label-snapshots-v5.1.json/records/42/disclaimer | Historical; current review incomplete |
H51-9791F2E9BD1F0749971623B3 | dosing.json/records/221/id | Historical; current review incomplete |
H51-2B01014BA615572617FA2527 | dosing.json/records/221/generic_name | Historical; current review incomplete |
H51-CD59DA329667A3E66F124E87 | dosing.json/records/221/coverage_status | Historical; current review incomplete |
H51-2DCAAB13C6E992196519C525 | dosing.json/records/221/package_insert/query_name | Historical; current review incomplete |
H51-F8B3E8E3CD4814CA7550F920 | dosing.json/records/221/package_insert/preferred_setid | Historical; current review incomplete |
H51-7C0EBDF445FD5F47755B8BEB | dosing.json/records/221/package_insert/product_and_route_must_match | Historical; current review incomplete |
H51-7C41885472A63AFCD13748FA | dosing.json/records/221/package_insert/live_current_label_enabled | Historical; current review incomplete |
H51-9D08B453CBC284375B786827 | dosing.json/records/221/package_insert/source_priority | Historical; current review incomplete |
H51-321420625DBE4D42CADE8DC8 | dosing.json/records/221/package_insert/direct_official_label_access_enabled | Historical; current review incomplete |
H51-254A1061458FAB30E0ABF2BA | dosing.json/records/221/package_insert/outbound_server_request_required | Historical; current review incomplete |
H51-6D7396EE6CFF52F5B8F94693 | dosing.json/records/221/package_insert/local_summary_status | Historical; current review incomplete |
H51-09D400D63F6F7925922F7DA3 | dosing.json/records/221/renal/classification | Historical; current review incomplete |
H51-1DCCF934FA15750F9CBD8848 | dosing.json/records/221/renal/summary | Historical; current review incomplete |
H51-5ED048D0CB66F8BEE60613B7 | dosing.json/records/221/renal/method_note | Historical; current review incomplete |
H51-38262BCEB7DE449D6A66480D | dosing.json/records/221/professional_sources/0 | Historical; current review incomplete |
H51-84B7E1B42EEBF083CE007DFD | dosing.json/records/221/professional_sources/0/label | Historical; current review incomplete |
H51-7A87528CD233DD04CFEFF192 | dosing.json/records/221/professional_sources/0/url | Historical; current review incomplete |
H51-0062B50762FAFB9BF2A7398E | dosing.json/records/221/professional_sources/0/kind | Historical; current review incomplete |
H51-04A6AF5C1612F7D4DE475F93 | dosing.json/records/221/professional_sources/1 | Historical; current review incomplete |
H51-E674D6C54E93A1008768C82D | dosing.json/records/221/professional_sources/1/label | Historical; current review incomplete |
H51-868182C20E34B7ABF8D761C5 | dosing.json/records/221/professional_sources/1/url | Historical; current review incomplete |
H51-03FA1DF30338BC6625F51E4F | dosing.json/records/221/professional_sources/1/kind | Historical; current review incomplete |
H51-CCFB5184DB043ED7AB3A48D9 | dosing.json/records/221/professional_sources/2 | Historical; current review incomplete |
H51-E6B1D07070992A993B16AA5D | dosing.json/records/221/professional_sources/2/label | Historical; current review incomplete |
H51-C76C289D21F88F0A0BC4DDBB | dosing.json/records/221/professional_sources/2/url | Historical; current review incomplete |
H51-C8ED5DBBE78950DC6C46E174 | dosing.json/records/221/professional_sources/2/kind | Historical; current review incomplete |
H51-9BA13BED9A99BDBE520E6CE1 | dosing.json/records/221/professional_sources/3 | Historical; current review incomplete |
H51-9476D300450DB3B644BBF3F4 | dosing.json/records/221/professional_sources/3/label | Historical; current review incomplete |
H51-3AE104229F75494E4D8687EF | dosing.json/records/221/professional_sources/3/url | Historical; current review incomplete |
H51-E3ACEE7951F805D9E0F76227 | dosing.json/records/221/professional_sources/3/kind | Historical; current review incomplete |
H51-DF93AF526C09246B54C95C14 | dosing.json/records/221/clinical_review/locally_normalized | Historical; current review incomplete |
H51-53035B5D572978DB72B181F2 | dosing.json/records/221/clinical_review/reviewed | Historical; current review incomplete |
H51-9F99056C641E905F7DA0839F | dosing.json/records/221/clinical_review/status | Historical; current review incomplete |
H51-645FE3D0959F18C478E70F23 | dosing.json/records/221/clinical_release_verification/audit_version | Historical; current review incomplete |
H51-A4B933761B5CB12F40A0D019 | dosing.json/records/221/clinical_release_verification/audited_on | Historical; current review incomplete |
H51-5072FDBC083F91AF5B516CFB | dosing.json/records/221/clinical_release_verification/level | Historical; current review incomplete |
H51-862FBFAD8DF7EEC084DFE570 | dosing.json/records/221/clinical_release_verification/release_gate | Historical; current review incomplete |
H51-55D66C733CCA6878F598378B | dosing.json/records/221/clinical_release_verification/exact_current_label_candidate | Historical; current review incomplete |
H51-C2985571115142FCEB9ED2F7 | dosing.json/records/221/clinical_release_verification/selected_setid | Historical; current review incomplete |
H51-FFD18CC76E5CCB884301B5B6 | dosing.json/records/221/clinical_release_verification/selected_label_title | Historical; current review incomplete |
H51-846064A93DBA8F8100299218 | dosing.json/records/221/clinical_release_verification/numeric_support_ratio | Historical; current review incomplete |
H51-A5C59FC1D0AA5F5E9316FA6A | dosing.json/records/221/clinical_release_verification/reference_url_count | Historical; current review incomplete |
H51-BFB9B77420A6707AAF439A06 | dosing.json/records/221/clinical_release_verification/broken_reference_count | Historical; current review incomplete |
H51-D250F9FDA4CD1380069E04FA | dosing.json/records/221/clinical_release_verification/point_of_use_confirmation_required | Historical; current review incomplete |
H51-DED50084BD139D154D2B156E | dosing.json/records/221/clinical_release_verification/note | Historical; current review incomplete |
H51-4A26CED636B259C641D58258 | dosing.json/records/221/clinical_release_verification/dailymed_search_url | Historical; current review incomplete |
H51-F469B93B9E0C4DBA8545D135 | first-look-v5.1.json/records/221/id | Historical; current review incomplete |
H51-E2CABEDABDBF92E910AF3EF9 | first-look-v5.1.json/records/221/generic_name | Historical; current review incomplete |
H51-3EB3C6247B1F5A2F11D3DE02 | first-look-v5.1.json/records/221/class | Historical; current review incomplete |
H51-E51ED40AC269B1E91AA4477F | first-look-v5.1.json/records/221/subclass | Historical; current review incomplete |
H51-34821E4644A30C0895AABC2C | first-look-v5.1.json/records/221/primary_uses/0 | Historical; current review incomplete |
H51-0116259AFACDDCEF0EC87B37 | first-look-v5.1.json/records/221/mechanism | Historical; current review incomplete |
H51-9EDE98EBF4EF874F29BD9FF0 | first-look-v5.1.json/records/221/mechanism_level | Historical; current review incomplete |
H51-D127E13C7BC11D61CD98965B | first-look-v5.1.json/records/221/basic_dosing_orientation | Historical; current review incomplete |
H51-84CD3F33D3F143D7D0120A11 | first-look-v5.1.json/records/221/administration_orientation | Historical; current review incomplete |
H51-58687F17516DDA7E89BC5479 | first-look-v5.1.json/records/221/renal_and_population_orientation | Historical; current review incomplete |
H51-2E6673BF668CB0191821C377 | first-look-v5.1.json/records/221/key_safety_orientation/0 | Historical; current review incomplete |
H51-0519C9C2AAF8EE1EDF15B9D3 | first-look-v5.1.json/records/221/key_safety_orientation/1 | Historical; current review incomplete |
H51-2E6671F4E131DE6017A0520E | first-look-v5.1.json/records/221/coverage_path | Historical; current review incomplete |
H51-78877942C34701761E687B5A | first-look-v5.1.json/records/221/coverage_path_label | Historical; current review incomplete |
H51-BEFC49E082B78C7138160551 | first-look-v5.1.json/records/221/official_label_url | Historical; current review incomplete |
H51-3A2D6E700A8FC01B4E955F16 | first-look-v5.1.json/records/221/legacy_title | Historical; current review incomplete |
H51-375689024B2425BC77F47841 | first-look-v5.1.json/records/221/review_note | Historical; current review incomplete |
H51-E03314AE538DEFC404BEE9EC | first-look-v5.1.json/records/221/search_text | Historical; current review incomplete |
H51-29C2D8DE2513151D8036DA0E | first-look-v5.1.json/records/221/official_search_url | Historical; current review incomplete |
H51-238F202C206F1B685A4B8B53 | first-look-v5.1.json/records/221/official_access_mode | Historical; current review incomplete |
H51-A2F3D18F8CC0B335F6907A8A | first-look-v5.1.json/records/221/official_access_url | Historical; current review incomplete |
H51-751FC70319304A353762DBE6 | first-look-v5.1.json/records/221/official_search_query | Historical; current review incomplete |
H51-7CA1931AF50763149CA6BF51 | first-look-v5.1.json/records/221/official_access_reason | Historical; current review incomplete |
H51-C175874966E1C43831E1D4A9 | first-look-v5.1.json/records/221/label_snapshot_available | Historical; current review incomplete |
H51-6F0F2030D12155E42145475B | first-look-v5.1.json/records/221/label_snapshot_setid | Historical; current review incomplete |
H51-1B5FC290DE3B48D179534113 | local-label-summaries-v3.8.json/summaries/16/id | Historical; current review incomplete |
H51-2525418BA157977720199B7D | local-label-summaries-v3.8.json/summaries/16/match_names/0 | Historical; current review incomplete |
H51-A6696C24E0E6BE492B3202DF | local-label-summaries-v3.8.json/summaries/16/match_names/1 | Historical; current review incomplete |
H51-E6C34ECEE5DAEE10FFD93332 | local-label-summaries-v3.8.json/summaries/16/label_title | Historical; current review incomplete |
H51-7D6E36CB74E46C20E4F10612 | local-label-summaries-v3.8.json/summaries/16/brand_names/0 | Historical; current review incomplete |
H51-4DA8C7A6FB44BBF4B20A4B99 | local-label-summaries-v3.8.json/summaries/16/formulation | Historical; current review incomplete |
H51-B3872F84BD036666AB600FFE | local-label-summaries-v3.8.json/summaries/16/reconstitution | Historical; current review incomplete |
H51-65A6F53CEE16502136BC3182 | local-label-summaries-v3.8.json/summaries/16/stock_concentration | Historical; current review incomplete |
H51-7B2D040A1FB2AE2295CEF2ED | local-label-summaries-v3.8.json/summaries/16/diluents | Historical; current review incomplete |
H51-9686E85F5C01EBDF899F0C74 | local-label-summaries-v3.8.json/summaries/16/final_concentration | Historical; current review incomplete |
H51-632B8CDDDE1B3A2ED495083E | local-label-summaries-v3.8.json/summaries/16/containers | Historical; current review incomplete |
H51-21D95DF2E638A12A913DD74D | local-label-summaries-v3.8.json/summaries/16/infusion_time | Historical; current review incomplete |
H51-36F4D1583832B65AC63BEB99 | local-label-summaries-v3.8.json/summaries/16/fluid_restriction | Historical; current review incomplete |
H51-6668259E53698B22A66962CC | local-label-summaries-v3.8.json/summaries/16/stability | Historical; current review incomplete |
H51-F025D976AD88130CE8BBCD33 | local-label-summaries-v3.8.json/summaries/16/line_filter | Historical; current review incomplete |
H51-BDC9517113E78FBFF9E4F0C1 | local-label-summaries-v3.8.json/summaries/16/adult_applicability | Historical; current review incomplete |
H51-93463EA17B93DC393FCFB5C2 | local-label-summaries-v3.8.json/summaries/16/pediatric_applicability | Historical; current review incomplete |
H51-A9F071B93B32D101E75CA6A7 | local-label-summaries-v3.8.json/summaries/16/neonatal_applicability | Historical; current review incomplete |
H51-06F0B4569AA378E17E691305 | local-label-summaries-v3.8.json/summaries/16/renal_dialysis | Historical; current review incomplete |
H51-4A92915A2BEBEA18DF02B075 | local-label-summaries-v3.8.json/summaries/16/key_warnings | Historical; current review incomplete |
H51-429C40C7945FF246A9EF854E | local-label-summaries-v3.8.json/summaries/16/catalog_id | Historical; current review incomplete |
H51-68F2748B0E41A48752D93E7E | local-label-summaries-v3.8.json/summaries/16/catalog_name | Historical; current review incomplete |
H51-DC63F968E8B294B61A89B7CD | local-label-summaries-v3.8.json/summaries/16/review_date | Historical; current review incomplete |
H51-5A626E8EECF536371DC3CFC1 | local-label-summaries-v3.8.json/summaries/16/source_type | Historical; current review incomplete |
H51-E242B47E6038F81F56658CF8 | local-label-summaries-v3.8.json/summaries/16/official_link_type | Historical; current review incomplete |
H51-1EB7D30FEC209D803945D878 | local-label-summaries-v3.8.json/summaries/16/official_label_url | Historical; current review incomplete |
H51-AB9EA6F9950F7BAEF8FC640A | local-label-summaries-v3.8.json/summaries/16/official_search_url | Historical; current review incomplete |
H51-B3496447FCB48F263E422C6E | local-label-summaries-v3.8.json/summaries/16/search_text | Historical; current review incomplete |
H51-8E77E52A83AD483F4BAE0D56 | local-label-summaries-v3.8.json/summaries/16/label_status | Historical; current review incomplete |
H51-C76F305AD8D3128944C7EBA6 | local-label-summaries-v3.8.json/summaries/16/label_status_level | Historical; current review incomplete |
H51-02E4FB76A547572A16557864 | preparation-assessments-v3.8.json/221/id | Historical; current review incomplete |
H51-F2CF0B10CB2F7D025084B802 | preparation-assessments-v3.8.json/221/name | Historical; current review incomplete |
H51-2459307814389279510B8A97 | preparation-assessments-v3.8.json/221/brands | Historical; current review incomplete |
H51-451CEF3CA6B18D8A060C248E | preparation-assessments-v3.8.json/221/therapeutic_class | Historical; current review incomplete |
H51-5EAF8E57FB421EDAE427DB9D | preparation-assessments-v3.8.json/221/review_version | Historical; current review incomplete |
H51-4A6AC86AE2DC92B6B8A91A7A | preparation-assessments-v3.8.json/221/review_date | Historical; current review incomplete |
H51-751B35C37A39BA08DF87FDAD | preparation-assessments-v3.8.json/221/release_status | Historical; current review incomplete |
H51-CABDA9AF35E31412BEA5DE20 | preparation-assessments-v3.8.json/221/market_status/status | Historical; current review incomplete |
H51-56E104B46604D1C04315ABC8 | preparation-assessments-v3.8.json/221/market_status/basis | Historical; current review incomplete |
H51-3282E84E495246CCC967B498 | preparation-assessments-v3.8.json/221/ten_point_assessment/exact_formulation | Historical; current review incomplete |
H51-6CBF681EA0204CE724E2B797 | preparation-assessments-v3.8.json/221/ten_point_assessment/reconstitution_concentration | Historical; current review incomplete |
H51-1306D6342FFCBEA8CB7B6B18 | preparation-assessments-v3.8.json/221/ten_point_assessment/maximum_or_recommended_final_concentration | Historical; current review incomplete |
H51-B4174DCC184E8B41A8B5B1EE | preparation-assessments-v3.8.json/221/ten_point_assessment/appropriate_standardized_containers | Historical; current review incomplete |
H51-82F6E13E8A24DF2A192425A1 | preparation-assessments-v3.8.json/221/ten_point_assessment/adult_dosing_range | Historical; current review incomplete |
H51-93C4B67753BA672C4EA89698 | preparation-assessments-v3.8.json/221/ten_point_assessment/pediatric_dosing_range | Historical; current review incomplete |
H51-AADE8795749C81B3C1E5E707 | preparation-assessments-v3.8.json/221/ten_point_assessment/neonatal_dosing_range | Historical; current review incomplete |
H51-3C091E1ADC4A8C7F8619D99F | preparation-assessments-v3.8.json/221/ten_point_assessment/infusion_time | Historical; current review incomplete |
H51-FCF97FA0945CCE2C4C6451E1 | preparation-assessments-v3.8.json/221/ten_point_assessment/fluid_restriction_alternatives | Historical; current review incomplete |
H51-3149B23F1CBCF037099E543A | preparation-assessments-v3.8.json/221/ten_point_assessment/current_manufacturer_labeling/setid | Historical; current review incomplete |
H51-CBD52DFCB58C92206CF59DDC | preparation-assessments-v3.8.json/221/ten_point_assessment/current_manufacturer_labeling/title | Historical; current review incomplete |
H51-2CDD19D8F65C2FBC1359BDB1 | preparation-assessments-v3.8.json/221/ten_point_assessment/current_manufacturer_labeling/published_date | Historical; current review incomplete |
H51-C72252A5DF3BB52083726B80 | preparation-assessments-v3.8.json/221/ten_point_assessment/current_manufacturer_labeling/manufacturer | Historical; current review incomplete |
H51-C491904B75102E74EF9CA4F2 | preparation-assessments-v3.8.json/221/ten_point_assessment/current_manufacturer_labeling/routes/0 | Historical; current review incomplete |
H51-DFBB67B21BBF6AFA2300A9AA | preparation-assessments-v3.8.json/221/ten_point_assessment/current_manufacturer_labeling/match_confidence | Historical; current review incomplete |
H51-C77DB6555F8B7F221BDF82A9 | preparation-assessments-v3.8.json/221/ten_point_assessment/current_manufacturer_labeling/url | Historical; current review incomplete |
H51-736327DEA5C3F79E379F4DDB | preparation-assessments-v3.8.json/221/field_provenance/exact_formulation/primary | Historical; current review incomplete |
H51-A1CC00A12AC0B93527B7A83A | preparation-assessments-v3.8.json/221/field_provenance/reconstitution_concentration/primary | Historical; current review incomplete |
H51-F3194E66E1E8AC2F0250016E | preparation-assessments-v3.8.json/221/field_provenance/maximum_or_recommended_final_concentration/primary | Historical; current review incomplete |
H51-35F1D64E72D6408B0360F8F7 | preparation-assessments-v3.8.json/221/field_provenance/appropriate_standardized_containers/primary | Historical; current review incomplete |
H51-120FE3E8049E8356380D9B90 | preparation-assessments-v3.8.json/221/field_provenance/adult_dosing_range/primary | Historical; current review incomplete |
H51-999FEC991323DEAC9B4EE3FF | preparation-assessments-v3.8.json/221/field_provenance/pediatric_dosing_range/primary | Historical; current review incomplete |
H51-CBC11A68A10A59AA28F988B6 | preparation-assessments-v3.8.json/221/field_provenance/neonatal_dosing_range/primary | Historical; current review incomplete |
H51-0BC186B8C0745AC5095F4401 | preparation-assessments-v3.8.json/221/field_provenance/infusion_time/primary | Historical; current review incomplete |
H51-53BDCAE722DAB5D035208069 | preparation-assessments-v3.8.json/221/field_provenance/fluid_restriction_alternatives/primary | Historical; current review incomplete |
H51-53E742354DE4500719DA33F6 | preparation-assessments-v3.8.json/221/field_provenance/current_manufacturer_labeling/primary | Historical; current review incomplete |
H51-097B5E4572E0E2B02EDBB723 | preparation-assessments-v3.8.json/221/population_applicability/adult/applicability | Historical; current review incomplete |
H51-635213027D55FB9DFD66357A | preparation-assessments-v3.8.json/221/population_applicability/adult/guide_generation_allowed | Historical; current review incomplete |
H51-51637D4EF70A59B94300237D | preparation-assessments-v3.8.json/221/population_applicability/pediatric/applicability | Historical; current review incomplete |
H51-1216F3674A391161018BCDC8 | preparation-assessments-v3.8.json/221/population_applicability/pediatric/guide_generation_allowed | Historical; current review incomplete |
H51-17990709FEDA8FBB92C0A05F | preparation-assessments-v3.8.json/221/population_applicability/neonatal/applicability | Historical; current review incomplete |
H51-8CAE0EF9EC317DD4490D0C4B | preparation-assessments-v3.8.json/221/population_applicability/neonatal/guide_generation_allowed | Historical; current review incomplete |
H51-1AE4929DF2399A1CD0AF58F5 | preparation-assessments-v3.8.json/221/route_presence/structured_dilution | Historical; current review incomplete |
H51-FEA83BE437B6D9EB6C92DD25 | preparation-assessments-v3.8.json/221/route_presence/iv_push | Historical; current review incomplete |
H51-C75E54FA76455E5A043DAEF9 | preparation-assessments-v3.8.json/221/route_presence/continuous_infusion | Historical; current review incomplete |
H51-2812A57AC20C22F24F430997 | preparation-assessments-v3.8.json/221/route_presence/pediatric_source | Historical; current review incomplete |
H51-DB04A13FF2EB7B2714E40171 | preparation-assessments-v3.8.json/221/route_presence/neonatal_source | Historical; current review incomplete |
H51-3ADE5C6B1EDB7D5A29EC709B | preparation-assessments-v3.8.json/221/legacy_reference/status | Historical; current review incomplete |
H51-B6123090FAC764CDCB1F46BB | preparation-assessments-v3.8.json/221/label_resolution/status | Historical; current review incomplete |
H51-019489DF59C75E7C1DBFA490 | preparation-assessments-v3.8.json/221/label_resolution/existing_setids/0 | Historical; current review incomplete |
H51-EF7CD852E013650E2E25DD4E | preparation-assessments-v3.8.json/221/label_resolution/official_url | Historical; current review incomplete |
H51-8CE2D8F80033A56EC964A8A3 | preparation-assessments-v3.8.json/221/label_resolution/review_date | Historical; current review incomplete |
H51-FF60F58F3B66ED34FF64E5C4 | preparation-assessments-v3.8.json/221/source_files/0 | Historical; current review incomplete |
H51-282D286B79CF6CA59380594C | preparation-assessments-v3.8.json/221/source_files/1 | Historical; current review incomplete |
H51-02DC717C0160E27729412DE6 | preparation-assessments-v3.8.json/221/source_files/2 | Historical; current review incomplete |
H51-DDD30658A81881D59D44E39C | preparation-assessments-v3.8.json/221/source_files/3 | Historical; current review incomplete |
H51-47E10B3C105207F622EA4C84 | preparation-assessments-v3.8.json/221/clinical_release_note | Historical; current review incomplete |
H51-0F717ABBC61A78F05B3DEEBE | preparation-assessments-v3.8.json/221/has_bundled_label_summary | Historical; current review incomplete |
H51-8610A490168A442629FD781B | preparation-assessments-v3.8.json/221/bundled_label_summary_id | Historical; current review incomplete |
H51-3DA83353304D00CBB787D1FB | preparation-assessments-v3.8.json/221/bundled_label_review_date | Historical; current review incomplete |
H51-39AA6633159B8C9C5A070E52 | preparation-assessments-v3.8.json/221/local_label_search | Historical; current review incomplete |
H51-9847126642531989EC48BEF7 | preparation-assessments-v3.8.json/221/aliases/0 | Historical; current review incomplete |
H51-2A5C0BBE35E6B8A21E3FFE4D | preparation-assessments-v3.8.json/221/aliases/1 | Historical; current review incomplete |
H51-4F4C6C34012631634E89AB70 | preparation-assessments-v3.8.json/221/aliases/2 | Historical; current review incomplete |
H51-5EB5058C52C6E8EDCA47D750 | preparation-assessments-v3.8.json/221/aliases/3 | Historical; current review incomplete |
H51-F5E878FE2B07BD6A2625D5E7 | preparation-assessments-v3.8.json/221/aliases/4 | Historical; current review incomplete |
H51-3826DA96DCB5BEDDE7A56956 | preparation-assessments-v3.8.json/221/local_label_summary/available | Historical; current review incomplete |
H51-9A4E5C076F3B3BB5714D2F10 | preparation-assessments-v3.8.json/221/local_label_summary/status_level | Historical; current review incomplete |
H51-D28E129187706D57F071AEBA | preparation-assessments-v3.8.json/221/local_label_summary/title | Historical; current review incomplete |
H51-072724CC765D79CD53D1CB60 | preparation-assessments-v3.8.json/221/local_label_summary/official_url | Historical; current review incomplete |
Open the original GlobalRPh site monograph (historical; not revalidated) (opens in a new tab)